Positive results from Phase IIb benralizumab study in severe asthma
- Details
- Category: AstraZeneca
AstraZeneca has announced that The Lancet Respiratory Medicine has published positive safety and efficacy data from a Phase IIb study evaluating benralizumab, a novel investigational monoclonal antibody, in patients with severe, uncontrolled asthma and elevated levels of eosinophils, a type of inflammatory white blood cell.
New data on the global economic impact and burden of preventable blindness and vision impairment
- Details
- Category: Novartis
To highlight the critical need for access to eye care and regular eye examinations, Novartis and its eye care division, Alcon, are introducing new data on World Sight Day, highlighting the economic impact and burden that blindness and vision impairment can have on societies and individuals across the globe.
GSK commits further funding to advance bioelectronics research with creation of $5 million Innovation Challenge Fund
- Details
- Category: GlaxoSmithKline
GSK has announced a $5 million Innovation Challenge Fund (ICF) to further encourage and advance collaborative research as part of its effort to develop bioelectronic medicines. The fund will support academic groups and small companies who want to develop solutions for GSK's Bioelectronics Innovation Challenge, which was developed by a group of leading scientists from around the world.
Novartis announces clinical collaboration to evaluate Bristol-Myers Squibb's novel immunotherapy in combination treatments for NSCLC
- Details
- Category: Novartis
Novartis announced today that it has entered into a clinical collaboration with Bristol-Myers Squibb Company (NYSE: BMY) to evaluate the safety, tolerability and preliminary efficacy of three molecularly targeted compounds in combination with Bristol-Myers Squibb's investigational PD-1 immune checkpoint inhibitor, Opdivo® (nivolumab), in Phase I/II trials of patients with non-small cell lung cancer (NSCLC).
Bayer closes acquisition of consumer care business of Merck & Co., Inc., United States, for USD 14.2 billion
- Details
- Category: Bayer
Bayer has completed the acquisition of the consumer care business of the U.S. pharmaceuticals group Merck & Co., Inc., Whitehouse Station, New Jersey. The transaction closed on October 1, 2014, following receipt of required antitrust approvals.
Pfizer and Kyowa Hakko Kirin to collaborate on immuno-oncology combination study
- Details
- Category: Pfizer
Pfizer Inc. (NYSE:PFE) and Kyowa Hakko Kirin (Tokyo:4151), have entered into an agreement to explore the therapeutic potential of the combination of Pfizer's PF-05082566, an investigational, fully humanized monoclonal antibody (mAb) that stimulates signaling through 4-1BB (CD-137), a protein involved in regulation of immune cell activation, proliferation and survival, with Kyowa Hakko Kirin's anti-CCR4 antibody mogamulizumab,
Novo Nordisk establishes new obesity research unit in Seattle
- Details
- Category: Novo Nordisk
Novo Nordisk has announced that the company will establish a new obesity research unit in Seattle, Washington, in the US. The new unit is a result of Novo Nordisk's increasing focus on treatment of obesity. Its main task will be to identify novel approaches and targets for obesity treatments while increasing the scientific understanding of existing obesity targets.
More Pharma News ...
- MedImmune and Cancer Research UK establish joint CRUK-MEDI Alliance Laboratory
- Boehringer Ingelheim and CureVac announce collaboration to develop next generation lung cancer immunotherapy
- Bristol-Myers Squibb and Pfizer announce charitable donations of more than $1 million to support cardiovascular education
- Merck to acquire Sigma-Aldrich to enhance position in attractive life science industry
- AstraZeneca and Lilly announce alliance to develop and commercialise BACE inhibitor AZD3293 for Alzheimer's disease
- Roche again ranked most sustainable healthcare company in the Dow Jones Sustainability Indices
- GSK joins with research councils in UK and South Africa to tackle non-communicable diseases